bioavailability of oral semaglutide Anatomical site absorption of semaglutide. (A) Gamma Oral GLP-1-Based Therapeutics in the

Affordable GIP + GLP-1 weight-loss injections for seniors on Medicare a dual-action shot from $140, overseen by a licensed care team, with your care covered

Understanding how your body responds to excess food while on treatment helps you make informed decisions and maintain progress toward your weight loss goals

PlexusDx breaks down the latest evidence on semaglutide use in AFib and how personalized genetic testing may guide treatment decisions

The obesity sector has witnessed robust GLP-1 deal making with pharma companies showing unprecedented appetite for strategic pharma deals.

Although use of glucagon-like peptide-1 agonists for diabetes and weight loss has soared with indications now expanding into liver diseases, specifically metabolic dysfunction-associated steatohepatitis, the jury is still out on its benefit.With the recent FDA approval of Rezdiffra (resmetirom, Madrigal Pharmaceuticals) for the treatment for MASH, the question is whether (and how) GLP-1s will fit